drugset / Trial / NCT03618784
Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid Arthritis
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Safety and Efficacy of FURESTEM-RA Inj. in Patients With Moderate to Severe Rheumatoid arthritis
Timeline
- Start
- 2018-07-11
- Primary completion
- 2021-10-05
- Completion
- 2022-05-13
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | FURESTEM-RA Inj | Cell therapy | 5e+07 cells | Intravenous |
| Subject | FURESTEM-RA Inj | Cell therapy | 1e+08 cells | Intravenous |